Home/Filings/4/0001209191-21-012423
4//SEC Filing

Hanley Jr. Michael Conick 4

Accession 0001209191-21-012423

CIK 0001636282other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 5:07 PM ET

Size

5.5 KB

Accession

0001209191-21-012423

Insider Transaction Report

Form 4
Period: 2021-02-17
Hanley Jr. Michael Conick
Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-02-17+135,000135,000 total
    Exercise: $7.35Exp: 2031-02-16Common Stock (135,000 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 17, 2021, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Issuer

Aeglea BioTherapeutics, Inc.

CIK 0001636282

Entity typeother

Related Parties

1
  • filerCIK 0001791413

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 5:07 PM ET
Size
5.5 KB